Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




US Panel Supports Cloning Only for Treating Disease

By Biotechdaily staff writers
Posted on 21 May 2002
A panel of scientists from the US National Academy of Sciences (Washington, DC, USA) has reported that it supports the cloning of embryos to treat disease but not the creation of clones to reproduce human beings, which it says is not safe and should be outlawed. More...
The panel was composed of 11 experts from leading US medical and educational centers who considered the scientific and medical aspects of human reproductive cloning.

While many experts are in favor of research or therapeutic cloning, very few are in favor of reproductive cloning, so the report did not come as a surprise. However, the report adds to the ongoing US controversy over cloning. The US Senate is about to consider new legislation to ban all forms of cloning, for any purpose whatever. The legislation is backed by US President Bush. The same position is also held by the US Conference of Catholic Bishops, which argues that creating and destroying embryos for research interferes with the sanctity of human life. Meanwhile, the Council on Bioethics, appointed by President Bush, has also been wrestling with the ethics of cloning. Although no members favor reproductive cloning, many disagree on therapeutic cloning.

In recommending a ban on reproductive cloning, the academy's panel noted that within five years the ban should be reviewed, to be reconsidered only if new findings indicate that the process is safe and there is broad national backing for reconsideration. Following testimony from three scientists who plan to attempt the cloning of a human being, the panel concluded that "no voluntary system that is established to restrict reproductive cloning is likely to be completely effective.”


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Electrolyte Analyzer
CBS-4000 (CBS-400)
Creatinine/eGFR Meter
StatSensor® Creatinine/eGFR Meter
Pipette Calibration System
Artel PCS®
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Alzheimer’s pathology can start 15 to 20 years before symptoms, and validated tools that reach patients earlier help pave the way for earlier detection. (Image Credit: Adobe Stock)

Alzheimer’s Blood Test Becomes First FDA-Cleared Option for Adults as Young as 40

C2N Diagnostics’ PrecivityAD2 blood test was cleared by the U.S. Food and Drug Administration (FDA) on August 20, 2026, for adults as young as 40 who are experiencing signs of cognitive impairment, according... Read more

Pathology

view channel
Image: Adrenal gland tumor stained with hematoxylin and eosin (top) and CYP11B2 (bottom) (Photo courtesy of Christofer Juhlin)

Simple Immunohistochemical Size Ratio Improves Classification of Primary Aldosteronism

Primary aldosteronism is a common but underdiagnosed cause of hypertension, in which excess aldosterone promotes salt retention and raises blood pressure. Identifying the dominant source of hormone overproduction... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.